Deadline: 18 April 2025
The Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) are accepting applications for the Enhanced TB Diagnostics and Adjunct Technologies Program for Sample Collection and Processing.
Objectives
- The specific objectives of this challenge will be to address one or all of the following:
- Test involving new sampling methods
- It is important to move away from sputum and towards more accessible.
- Easier to collect samples for TB diagnosis. It is also important to assess the suitability of other sample types, such as saliva or blood for TB testing.
- Self-Sample Blood Collection Devices (Phlebotomist-free blood collection)
- Sample Collection for MTB
- Sample Lysis Devices (Instrument-free lysis) for TB lysis
- Sample Clean up and Analyte Concentration
- New testing technologies
- Test involving new sampling methods
- Ideally, the proposal will:
- Solicit variety of upstream testing solutions that make sample collection, preparation, and lysis simpler, less expensive, and self-administered PoC or near- to-care tests;
- Diagnostics for underserved populations, such as children and individuals with disseminated and/or paucibacillary TB;
- Product candidates that detect TB using specimens other than sputum (blood, serum, urine, stool, breath, swabs), enabling the identification of extrapulmonary or paucibacillary TB in adult and pediatric patients
- Solutions or diagnostics that may be able to overcome the infrastructure and cost- related drawbacks of current diagnostic techniques
- The assessment of new TB diagnostic approaches in the context of current clinical algorithms in TB-endemic nations are also noteworthy.
- Brief laboratory tests on a diagnostic prototype or prototypes to verify functionality and viability prior to a clinical review.
- Place a strong emphasis on systematically observing, validating, and quantifying the improved outcomes balanced with cost-effectiveness from its use.
Eligibility Criteria
- This RFP is India-led; the programme is open to nonprofit organizations (society, trust and foundation), for-profit companies (start-ups), government agencies, individuals, and academic and research institutions.
For more information, visit BIRAC.